Telix Pharmaceuticals (TLX) Finished Goods (2023 - 2024)

Generated on {Timestamp} © BusinessQuant.com

Generated on {Timestamp} Powered by

Telix Pharmaceuticals (TLX) has disclosed Finished Goods for 2 consecutive years, with $9.2 million as the latest value for Q4 2024.

• Quarterly Finished Goods rose 286.24% to $9.2 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $9.2 million through Dec 2024, up 286.24% year-over-year, with the annual reading at $9.2 million for FY2024, 286.24% up from the prior year.
• Finished Goods for Q4 2024 was $9.2 million at Telix Pharmaceuticals, up from $2.4 million in the prior quarter.
• The five-year high for Finished Goods was $9.2 million in Q4 2024, with the low at $2.4 million in Q4 2023.

Peer Comparison